Home | COMETRIQ® (cabozantinib)
WEBCOMETRIQ is a prescription medicine used to treat people with medullary thyroid cancer (MTC) that has spread to other parts of the body (called metastatic MTC). It is not known if COMETRIQ is safe and effective in children.
Cometriq: Side Effects, Dosage & Uses - Drugs.com
WEBSep 22, 2022 · Cometriq is a prescription medicine used to treat thyroid cancer that has spread to other parts of the body. The Cabometyx brand of cabozantinib is used to treat advanced kidney cancer and liver cancer in people who have been previously treated with sorafenib (Nexavar).
COMETRIQ® (cabozantinib) For Healthcare Professionals
WEBCOMETRIQ ® (cabozantinib) is indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC) Attack from multiple angles. COMETRIQ has been shown to inhibit the activity of MET; VEGFR-1, -2, and -3; RET; and other receptor tyrosine kinases, in vitro 1.
Cometriq (Cabozantinib Capsules): Side Effects, Uses, Dosage
WEBSep 5, 2023 · COMETRIQ ® (Ko-me-trik) (cabozantinib) capsules, for oral use. What is COMETRIQ? COMETRIQ is a prescription medicine used to treat people with medullary thyroid cancer that has spread to other parts of the body. It is not known if COMETRIQ is safe and effective in children.
Cometriq Oral: Uses, Side Effects, Interactions, Pictures ... - WebMD
WEBFind patient medical information for Cometriq oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Cometriq: Uses, Taking, Side Effects, Warnings - Medicine.com
WEBCometriq is a prescription medicine used to treat people with medullary thyroid cancer that has spread to other parts of the body. It is not known if Cometriq is safe and effective in children. What should I tell my healthcare provider before taking Cometriq?
Cabozantinib - Wikipedia
WEBCabozantinib, sold under the brand names Cometriq and Cabometyx among others, is an anti-cancer medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. [ 9][ 10] It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. [ 8][ 7] It was discovered and d...
Cometriq, Cabometyx (cabozantinib) dosing, indications, …
WEBIndicated in combination with nivolumab for first-line treatment of advanced renal cell carcinoma (RCC) Cabozantinib 40 mg PO qDay PLUS nivolumab 240 mg IV q2Weeks or 480 mg IV q4Weeks....
Cometriq | European Medicines Agency (EMA)
WEBcabozantinib. It is used to treat adults with medullary thyroid cancer, a type of cancer originating in the cells in the thyroid gland that produce the hormone calcitonin. Cometriq is used when the cancer cannot be removed by surgery and has progressed or spread to other parts of the body.
What is COMETRIQ®? | COMETRIQ® (cabozantinib)
WEBCOMETRIQ is a prescription medicine used to treat people with medullary thyroid cancer (MTC) that has spread to other parts of the body (called metastatic MTC). It is not known if COMETRIQ is safe and effective in children.
- Some results have been removed